| __timestamp | Viking Therapeutics, Inc. | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 1244910 | 2999000 |
| Thursday, January 1, 2015 | 5029636 | 10393000 |
| Friday, January 1, 2016 | 4846776 | 15994000 |
| Sunday, January 1, 2017 | 5329003 | 26975000 |
| Monday, January 1, 2018 | 7121000 | 39509000 |
| Tuesday, January 1, 2019 | 9128000 | 48869000 |
| Wednesday, January 1, 2020 | 10731000 | 42510000 |
| Friday, January 1, 2021 | 10701000 | 46105000 |
| Saturday, January 1, 2022 | 16121000 | 50513000 |
| Sunday, January 1, 2023 | 37021000 | 51292000 |
Unleashing the power of data
In the competitive world of biotechnology, managing operational expenses is crucial for success. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Viking Therapeutics, Inc. and Wave Life Sciences Ltd. over the past decade.
From 2014 to 2023, Viking Therapeutics has shown a remarkable increase in SG&A efficiency. Starting with expenses of approximately $1.2 million in 2014, they have grown to $37 million by 2023, reflecting a strategic expansion. In contrast, Wave Life Sciences began with $3 million in 2014 and reached $51 million in 2023, indicating a more aggressive growth strategy.
While both companies have increased their SG&A expenses, Viking's growth rate is more than 29 times its initial value, compared to Wave's 17-fold increase. This suggests Viking's more conservative approach may yield better long-term sustainability.
Who Optimizes SG&A Costs Better? Sanofi or Viking Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Gilead Sciences, Inc. and Viking Therapeutics, Inc.
Incyte Corporation and Viking Therapeutics, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Viatris Inc. and Wave Life Sciences Ltd.
Walgreens Boots Alliance, Inc. and Wave Life Sciences Ltd.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Verona Pharma plc vs Wave Life Sciences Ltd. Trends and Insights
Who Optimizes SG&A Costs Better? Apellis Pharmaceuticals, Inc. or Viking Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Viking Therapeutics, Inc. and MorphoSys AG
Cost Management Insights: SG&A Expenses for Viking Therapeutics, Inc. and Supernus Pharmaceuticals, Inc.
Viking Therapeutics, Inc. and Evotec SE: SG&A Spending Patterns Compared
ImmunityBio, Inc. and Wave Life Sciences Ltd.: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Wave Life Sciences Ltd. and Travere Therapeutics, Inc.